QQ客服 官方微博 反馈留言

	The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)
	Si, X.; Zhang, L.; Wang, H.; Zhang, X.; Wang, M.; Han, B.; Li, K.; Wang, Q.; Shi, J.; Wang, Z.
刊名	JOURNAL OF THORACIC ONCOLOGY
	2018
卷号	13页码:S505-S505
关键词	non-small cell lung cancer quality of life Anlotinib
ISSN号	1556-0864
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2912888
专题	西安交通大学
推荐引用方式 GB/T 7714	Si, X.,Zhang, L.,Wang, H.,et al. The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)[J]. JOURNAL OF THORACIC ONCOLOGY,2018,13:S505-S505.
APA	Si, X..,Zhang, L..,Wang, H..,Zhang, X..,Wang, M..,...&Wang, D..(2018).The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303).JOURNAL OF THORACIC ONCOLOGY,13,S505-S505.
MLA	Si, X.,et al."The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)".JOURNAL OF THORACIC ONCOLOGY 13(2018):S505-S505.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。